semaglutide salts The FDA has received reports

Research indicates that GLP-1 drugs slow gastric motility, potentially allowing NSAIDs to remain in contact with stomach tissue longer than intended

Ozempic maker Novo Nordisk is gearing up to launch its popular weight loss drug Wegovy in China, but it plans to restrict initial sales of the medication in order to not deplete supply for the rest of the world

This approach also makes side effect management more straightforward since new symptoms can be attributed to the most recently added compound

His lawsuit alleges the company engaged in negligence, misleading marketing, failure to warn, and consistently downplayed the risks associated with the drug